235 related articles for article (PubMed ID: 20497634)
21. A novel Y331X nonsense mutation in TNFRSF1A gene in two unrelated Turkish families with periodic fever syndrome.
Kutukculer N; Gulez N; Karaca N; Aksu G; Berdeli A
Int J Immunogenet; 2010 Feb; 37(1):21-5. PubMed ID: 19804406
[TBL] [Abstract][Full Text] [Related]
22. Neurological phenotypes in patients with NLRP3-, MEFV-, and TNFRSF1A low-penetrance variants.
Mulazzani E; Wagner D; Havla J; Schlüter M; Meinl I; Gerdes LA; Kümpfel T
J Neuroinflammation; 2020 Jun; 17(1):196. PubMed ID: 32563262
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes.
Aganna E; Hammond L; Hawkins PN; Aldea A; McKee SA; van Amstel HK; Mischung C; Kusuhara K; Saulsbury FT; Lachmann HJ; Bybee A; McDermott EM; La Regina M; Arostegui JI; Campistol JM; Worthington S; High KP; Molloy MG; Baker N; Bidwell JL; Castañer JL; Whiteford ML; Janssens-Korpola PL; Manna R; Powell RJ; Woo P; Solis P; Minden K; Frenkel J; Yagüe J; Mirakian RM; Hitman GA; McDermott MF
Arthritis Rheum; 2003 Sep; 48(9):2632-44. PubMed ID: 13130484
[TBL] [Abstract][Full Text] [Related]
24. Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-
Gaggiano C; Vitale A; Obici L; Merlini G; Soriano A; Viapiana O; Cattalini M; Maggio MC; Lopalco G; Montin D; Jaber MA; Dagna L; Manna R; Insalaco A; Piga M; La Torre F; Berlengiero V; Gelardi V; Ciarcia L; Emmi G; Ruscitti P; Caso F; Cimaz R; Hernández-Rodríguez J; Parronchi P; Sicignano LL; Verrecchia E; Iannone F; Sota J; Grosso S; Salvarani C; Frediani B; Giacomelli R; Mencarelli MA; Renieri A; Rigante D; Cantarini L
Mediators Inflamm; 2020; 2020():8562485. PubMed ID: 32831641
[TBL] [Abstract][Full Text] [Related]
25. The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.
Dodé C; André M; Bienvenu T; Hausfater P; Pêcheux C; Bienvenu J; Lecron JC; Reinert P; Cattan D; Piette JC; Szajnert MF; Delpech M; Grateau G;
Arthritis Rheum; 2002 Aug; 46(8):2181-8. PubMed ID: 12209523
[TBL] [Abstract][Full Text] [Related]
26. A novel mutation in the third extracellular domain of the tumor necrosis factor receptor 1 in a Finnish family with autosomal-dominant recurrent fever.
Nevala H; Karenko L; Stjernberg S; Raatikainen M; Suomalainen H; Lagerstedt A; Rauta J; McDermott MF; Peterson P; Pettersson T; Ranki A
Arthritis Rheum; 2002 Apr; 46(4):1061-6. PubMed ID: 11953985
[TBL] [Abstract][Full Text] [Related]
27. Autoinflammatory diseases and cardiovascular manifestations.
Rigante D; Cantarini L; Imazio M; Lucherini OM; Sacco E; Galeazzi M; Brizi MG; Brucato A
Ann Med; 2011 Aug; 43(5):341-6. PubMed ID: 21284530
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel mevalonate kinase gene mutation in combination with the common MVK V377I substitution and the low-penetrance TNFRSF1A R92Q mutation.
Hoffmann F; Lohse P; Stojanov S; Shin YS; Renner ED; Kéry A; Zellerer S; Belohradsky BH
Eur J Hum Genet; 2005 Apr; 13(4):510-2. PubMed ID: 15657603
[TBL] [Abstract][Full Text] [Related]
29. The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.
Hull KM; Drewe E; Aksentijevich I; Singh HK; Wong K; McDermott EM; Dean J; Powell RJ; Kastner DL
Medicine (Baltimore); 2002 Sep; 81(5):349-68. PubMed ID: 12352631
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene.
Ravet N; Rouaghe S; Dodé C; Bienvenu J; Stirnemann J; Lévy P; Delpech M; Grateau G
Ann Rheum Dis; 2006 Sep; 65(9):1158-62. PubMed ID: 16569687
[TBL] [Abstract][Full Text] [Related]
31. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ
Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435
[TBL] [Abstract][Full Text] [Related]
32. A novel missense mutation in tumour necrosis factor receptor superfamily 1A (TNFRSF1A) gene found in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with high serum interleukin (IL)-22.
Nakamura M; Tokura Y
Eur J Dermatol; 2010; 20(4):508-9. PubMed ID: 20400394
[No Abstract] [Full Text] [Related]
33. Phenotypic variability in two patients with tumor necrosis factor receptor associated periodic fever syndrome emphasizes a rare manifestation: Immunoglobulin A nephropathy.
Balci S; Kisla Ekinci RM; Melek E; Atmis B; Bisgin A; Yilmaz M
Eur J Med Genet; 2020 Apr; 63(4):103780. PubMed ID: 31586650
[TBL] [Abstract][Full Text] [Related]
34. Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics.
Lainka E; Neudorf U; Lohse P; Timmann C; Stojanov S; Huss K; von Kries R; Niehues T
Rheumatology (Oxford); 2009 Aug; 48(8):987-91. PubMed ID: 19541728
[TBL] [Abstract][Full Text] [Related]
35. TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept.
Jesus AA; Oliveira JB; Aksentijevich I; Fujihira E; Carneiro-Sampaio MM; Duarte AJ; Silva CA
Eur J Pediatr; 2008 Dec; 167(12):1421-5. PubMed ID: 18408954
[TBL] [Abstract][Full Text] [Related]
36. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
[TBL] [Abstract][Full Text] [Related]
37. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
[TBL] [Abstract][Full Text] [Related]
38. Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever.
Marek-Yagel D; Berkun Y; Padeh S; Lidar M; Shinar Y; Bar-Joseph I; Reznik-Wolf H; Langevitz P; Livneh A; Pras E
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1294-8. PubMed ID: 20506103
[TBL] [Abstract][Full Text] [Related]
39. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
[TBL] [Abstract][Full Text] [Related]
40. Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types.
Huggins ML; Radford PM; McIntosh RS; Bainbridge SE; Dickinson P; Draper-Morgan KA; Tighe PJ; Powell RJ; Todd I
Arthritis Rheum; 2004 Aug; 50(8):2651-9. PubMed ID: 15334481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
